Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roopali Gandhi

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
International Journal of Molecular Sciences|May 13, 2023
Defective Induction of IL-27-Mediated Immunoregulation by Myeloid DCs in Multiple SclerosisFelipe von Glehn, Nathalie Pochet, Bibek Thapa, et al.
Journal of Neuroinflammation|December 31, 2015
Identification of a novel mechanism of action of fingolimod (FTY720) on human effector T cell function through TCF-1 upregulationMaria Antonietta Mazzola, Radhika Raheja, Gopal Murugaiyan, et al.
Crohn'S & Colitis 360|August 20, 2019
Immunologic Alterations Associated With Oral Delivery of Anti-CD3 (OKT3) Monoclonal Antibodies in Patients With Moderate-to-Severe Ulcerative ColitisElisa K Boden, James B Canavan, Christopher J Moran, et al.
JAMA Neurology|January 24, 2017
Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis SeverityKeren Regev, Brian C Healy, Fariha Khalid, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 4, 2018
Identification of MS-specific serum miRNAs in an international multicenter studyKeren Regev, Brian C Healy, Anu Paul, et al.
The Journal of Clinical Investigation|March 17, 2022
microRNA-92a promotes CNS autoimmunity by modulating the regulatory and inflammatory T cell balanceMai Fujiwara, Radhika Raheja, Lucien P Garo, et al.
Journal of Clinical Immunology|September 17, 2009
Oral administration of OKT3 monoclonal antibody to human subjects induces a dose-dependent immunologic effect in T cells and dendritic cellsYaron Ilan, Ehud Zigmond, Gadi Lalazar, et al.
Journal of Extracellular Vesicles|September 1, 2015
Extracellular RNAs: development as biomarkers of human diseaseJoseph F Quinn, Tushar Patel, David Wong, et al.
Nature Communications|June 29, 2016
Alterations of the human gut microbiome in multiple sclerosisSushrut Jangi, Roopali Gandhi, Laura M Cox, et al.
Genome Biology|February 11, 2020
A post-transcriptional program of chemoresistance by AU-rich elements and TTP in quiescent leukemic cellsSooncheol Lee, Douglas Micalizzi, Samuel S Truesdell, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
International Journal of Molecular Sciences|May 13, 2023
Defective Induction of IL-27-Mediated Immunoregulation by Myeloid DCs in Multiple SclerosisFelipe von Glehn, Nathalie Pochet, Bibek Thapa, et al.
Journal of Neuroinflammation|December 31, 2015
Identification of a novel mechanism of action of fingolimod (FTY720) on human effector T cell function through TCF-1 upregulationMaria Antonietta Mazzola, Radhika Raheja, Gopal Murugaiyan, et al.
Crohn'S & Colitis 360|August 20, 2019
Immunologic Alterations Associated With Oral Delivery of Anti-CD3 (OKT3) Monoclonal Antibodies in Patients With Moderate-to-Severe Ulcerative ColitisElisa K Boden, James B Canavan, Christopher J Moran, et al.
JAMA Neurology|January 24, 2017
Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis SeverityKeren Regev, Brian C Healy, Fariha Khalid, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 4, 2018
Identification of MS-specific serum miRNAs in an international multicenter studyKeren Regev, Brian C Healy, Anu Paul, et al.
The Journal of Clinical Investigation|March 17, 2022
microRNA-92a promotes CNS autoimmunity by modulating the regulatory and inflammatory T cell balanceMai Fujiwara, Radhika Raheja, Lucien P Garo, et al.
Journal of Clinical Immunology|September 17, 2009
Oral administration of OKT3 monoclonal antibody to human subjects induces a dose-dependent immunologic effect in T cells and dendritic cellsYaron Ilan, Ehud Zigmond, Gadi Lalazar, et al.
Journal of Extracellular Vesicles|September 1, 2015
Extracellular RNAs: development as biomarkers of human diseaseJoseph F Quinn, Tushar Patel, David Wong, et al.
Nature Communications|June 29, 2016
Alterations of the human gut microbiome in multiple sclerosisSushrut Jangi, Roopali Gandhi, Laura M Cox, et al.
Genome Biology|February 11, 2020
A post-transcriptional program of chemoresistance by AU-rich elements and TTP in quiescent leukemic cellsSooncheol Lee, Douglas Micalizzi, Samuel S Truesdell, et al.
Pageof 5